BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15219517)

  • 21. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.
    Inoue T; Sata M; Hikichi Y; Sohma R; Fukuda D; Uchida T; Shimizu M; Komoda H; Node K
    Circulation; 2007 Feb; 115(5):553-61. PubMed ID: 17261663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
    Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
    J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy.
    Clavijo LC; Steinberg DH; Torguson R; Kuchulakanti PK; Chu WW; Fournadjiev J; Satler LF; Kent KM; Suddath WO; Waksman R; Pichard AD
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):873-8. PubMed ID: 17086529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burr erosion in rotational ablation of metallic coronary stent: an electron microscopic study.
    Ho PC; Weatherby TM; Dunlap M
    J Interv Cardiol; 2010 Jun; 23(3):233-9. PubMed ID: 20412380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Directional coronary atherectomy vs. rotational atherectomy for the treatment of in-stent restenosis of native coronary arteries.
    Sanchez PL; Rodriguez-Alemparte M; Colon-Hernandez PJ; Pomerantsev E; Inglessis I; Mahdi NA; Leinbach RC; Palacios IF
    Catheter Cardiovasc Interv; 2003 Feb; 58(2):155-61. PubMed ID: 12552536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory response after coronary angioplasty - mechanisms and significance].
    Koziński M; Kubica J
    Kardiol Pol; 2006 Jul; 64(7):771-4; author reply 775. PubMed ID: 16886140
    [No Abstract]   [Full Text] [Related]  

  • 27. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results.
    Strauss BH; Umans VA; van Suylen RJ; de Feyter PJ; Marco J; Robertson GC; Renkin J; Heyndrickx G; Vuzevski VD; Bosman FT
    J Am Coll Cardiol; 1992 Dec; 20(7):1465-73. PubMed ID: 1360479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Palmaz-Schatz stent was partially resected by directional coronary atherectomy device to treat a stent-jailed side branch.
    Urasawa K; Oyama N; Sakai H
    J Invasive Cardiol; 2004 Oct; 16(10):606-7. PubMed ID: 15505364
    [No Abstract]   [Full Text] [Related]  

  • 30. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein.
    Skowasch D; Jabs A; Andrié R; Lüderitz B; Bauriedel G
    Heart; 2005 Apr; 91(4):535-6. PubMed ID: 15772225
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.
    Schober A; Hoffmann R; Oprée N; Knarren S; Iofina E; Hutschenreuter G; Hanrath P; Weber C
    Am J Cardiol; 2005 Oct; 96(8):1116-22. PubMed ID: 16214449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directional coronary atherectomy and implantation of drug-eluting stents in selected bifurcation lesions: a logical combination waiting evidence.
    Colombo A
    J Am Coll Cardiol; 2007 Nov; 50(20):1946-7. PubMed ID: 17996558
    [No Abstract]   [Full Text] [Related]  

  • 34. Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study.
    Ribichini F; Ferrero V; Rognoni A; Marino P; Brunelleschi S; Vassanelli C
    J Interv Cardiol; 2007 Apr; 20(2):114-21. PubMed ID: 17391219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):935-9. PubMed ID: 15500438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An optimal acute result after directional atherectomy or stent placement reduces the risk of subsequent restenosis.
    Baim DS; Kuntz RE; Carrozza JP; Cohen DJ
    J Invasive Cardiol; 1994 Apr; 6(3):85-8. PubMed ID: 10147475
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.